Analgesics (Pharmacies) - Singapore

  • Singapore
  • Revenue in the Analgesics market is projected to reach US$174.20m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 7.21%, resulting in a market volume of US$246.70m by 2029.
  • In global comparison, most revenue will be generated in China (US$5,028.00m in 2024).
  • In relation to total population figures, per person revenues of US$28.79 are generated in 2024.

Key regions: China, South Korea, Canada, India, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Analgesics (Pharmacies) market in Singapore has been experiencing steady growth in recent years, driven by customer preferences for over-the-counter pain relief medications, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in Singapore have been shifting towards self-medication and convenience, which has contributed to the growth of the Analgesics (Pharmacies) market. Consumers are increasingly seeking quick and accessible solutions for pain relief, and over-the-counter analgesics provide a convenient option for managing minor aches and pains without the need for a prescription. This preference for self-medication is driven by a desire for immediate relief and the convenience of being able to purchase these medications at pharmacies without the need for a doctor's visit. Trends in the market have also played a role in the growth of the Analgesics (Pharmacies) market in Singapore. The rise of e-commerce and online pharmacies has made it easier for consumers to access a wide range of analgesic products from the comfort of their own homes. This has increased competition among pharmacies, leading to a wider variety of products and competitive pricing. Additionally, the growing emphasis on health and wellness has also contributed to the demand for analgesics, as consumers are increasingly seeking natural and alternative pain relief options. Local special circumstances in Singapore have further fueled the growth of the Analgesics (Pharmacies) market. Singapore has a high population density and a busy urban lifestyle, which often leads to stress, fatigue, and musculoskeletal issues. As a result, there is a constant demand for pain relief medications to alleviate these common ailments. Additionally, Singapore has a well-developed healthcare system and a high level of healthcare awareness among its population, which further drives the demand for analgesics. Underlying macroeconomic factors have also played a role in the growth of the Analgesics (Pharmacies) market in Singapore. The country has a strong economy with high levels of disposable income, enabling consumers to afford over-the-counter medications. Singapore also has a well-regulated pharmaceutical industry, ensuring the quality and safety of analgesic products available in the market. These factors contribute to consumer confidence in purchasing and using analgesics, further driving market growth. In conclusion, the Analgesics (Pharmacies) market in Singapore is experiencing steady growth due to customer preferences for self-medication and convenience, trends in the market such as the rise of e-commerce and the emphasis on health and wellness, local special circumstances such as a high population density and healthcare awareness, and underlying macroeconomic factors including a strong economy and a well-regulated pharmaceutical industry.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)